BDX Q1 2020 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q1 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.2B+1.6% YoY

Gross Profit

$2.0B46.8% margin

Operating Income

$501M11.9% margin

Net Income

$278M6.6% margin

EPS (Diluted)

$0.87

QoQ Revenue Growth

-7.8%

Cash Flow

Operating Cash Flow

$714M

Free Cash Flow

$541M

Stock-Based Comp.

$82M

Balance Sheet

Total Assets

$52.0B

Total Liabilities

$30.8B

Stockholders' Equity

$21.2B

Cash & Equivalents

$560M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.2B	$4.2B	+1.6%
Gross Profit	$2.0B	$2.0B	+0.3%
Operating Income	$501M	$888M	-43.6%
Net Income	$278M	$599M	-53.6%

Revenue Segments

Medical

$2.1B49%

Life Sciences

$1.1B27%

Interventional

$1.0B24%

Geographic Segments

UNITED STATES

$2.4B58%

Non-US

$1.8B42%